Roger Eg Schutgens Selected Research

Idiopathic Pulmonary Fibrosis

1/2018

Should vitamin K be supplemented instead of antagonised in patients with idiopathic pulmonary fibrosis?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roger Eg Schutgens Research Topics

Disease

2	Hemorrhage 01/2019 - 01/2018
1	von Willebrand Diseases (von Willebrand's Disease) 01/2019
1	Hemophilia A (Haemophilia) 01/2019
1	Vascular Calcification 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Thromboembolism 01/2018
1	Idiopathic Pulmonary Fibrosis 01/2018

Drug/Important Bio-Agent (IBA)

2	Tranexamic Acid (AMCA)FDA Link 01/2019 - 01/2018
2	Aminocaproic Acid (6 Aminocaproic Acid)FDA LinkGeneric 01/2019 - 01/2018
2	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2019 - 01/2018
2	Vitamin K FDA Link 01/2018 - 01/2018
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2019
1	Factor VIII (Coagulation Factor VIII)IBA 01/2019
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2019
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2019
1	AnticoagulantsIBA 01/2018

Therapy/Procedure

2	Oral Surgery (Maxillofacial Surgery) 01/2019 - 01/2018
2	Therapeutics 01/2019 - 01/2018
1	Drug Tapering 01/2018